Castlight Health (CSLT) Earning Somewhat Positive Media Coverage, Analysis Finds

Media coverage about Castlight Health (NYSE:CSLT) has trended somewhat positive this week, according to Accern Sentiment. The research firm identifies positive and negative press coverage by analyzing more than 20 million news and blog sources in real-time. Accern ranks coverage of companies on a scale of negative one to one, with scores nearest to one being the most favorable. Castlight Health earned a daily sentiment score of 0.17 on Accern’s scale. Accern also gave media coverage about the software maker an impact score of 45.6488903203992 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the near term.

Castlight Health (NYSE CSLT) traded down $0.15 during trading hours on Friday, reaching $4.05. The company’s stock had a trading volume of 188,700 shares, compared to its average volume of 325,167. The company has a market cap of $541.64, a P/E ratio of -8.62 and a beta of 1.66. Castlight Health has a 52 week low of $3.05 and a 52 week high of $4.75. The company has a current ratio of 1.94, a quick ratio of 1.94 and a debt-to-equity ratio of 0.03.

Castlight Health (NYSE:CSLT) last announced its quarterly earnings results on Wednesday, October 25th. The software maker reported ($0.05) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.07) by $0.02. The business had revenue of $34.60 million for the quarter, compared to the consensus estimate of $34.61 million. Castlight Health had a negative return on equity of 32.57% and a negative net margin of 45.14%. The business’s revenue was up 35.7% on a year-over-year basis. During the same quarter last year, the business posted ($0.05) EPS. analysts anticipate that Castlight Health will post -0.43 earnings per share for the current fiscal year.

CSLT has been the subject of a number of recent research reports. Cantor Fitzgerald reiterated a “hold” rating and issued a $5.00 target price on shares of Castlight Health in a research note on Wednesday, October 25th. Chardan Capital reduced their price target on Castlight Health from $6.50 to $6.30 and set a “buy” rating for the company in a report on Thursday, October 26th. BidaskClub downgraded Castlight Health from a “sell” rating to a “strong sell” rating in a report on Thursday, November 9th. Zacks Investment Research raised Castlight Health from a “hold” rating to a “buy” rating and set a $4.50 price target for the company in a report on Monday, October 30th. Finally, Canaccord Genuity reissued a “buy” rating and issued a $7.00 price target on shares of Castlight Health in a report on Thursday, October 26th. Three investment analysts have rated the stock with a sell rating, three have given a hold rating and three have issued a buy rating to the company. The stock presently has an average rating of “Hold” and a consensus price target of $5.22.

In related news, CFO Mangini Siobhan Nolan sold 8,866 shares of the firm’s stock in a transaction that occurred on Friday, November 17th. The stock was sold at an average price of $3.70, for a total value of $32,804.20. Following the sale, the chief financial officer now directly owns 78,561 shares in the company, valued at approximately $290,675.70. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, CEO John C. Doyle sold 13,686 shares of the firm’s stock in a transaction that occurred on Friday, November 17th. The shares were sold at an average price of $3.71, for a total value of $50,775.06. Following the completion of the sale, the chief executive officer now owns 123,705 shares in the company, valued at $458,945.55. The disclosure for this sale can be found here. In the last three months, insiders sold 22,778 shares of company stock worth $84,411. Company insiders own 37.43% of the company’s stock.

WARNING: This piece was first published by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are accessing this piece on another domain, it was illegally stolen and republished in violation of United States and international copyright & trademark laws. The original version of this piece can be viewed at https://www.dispatchtribunal.com/2018/01/19/castlight-health-cslt-receives-media-impact-score-of-0-17.html.

About Castlight Health

Castlight Health, Inc offers a health benefits platform that engages employees to make healthcare decisions, and enables employers to communicate and measure their benefit programs. The Company operates through cloud-based products segment. Its technology offering aggregates data and applies analytics to make healthcare data transparent.

Insider Buying and Selling by Quarter for Castlight Health (NYSE:CSLT)

Receive News & Ratings for Castlight Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Castlight Health and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply